More and better kinds of screening as well as new, more targeted treatments are making breast cancer less deadly.

An immuno-based treatment targeting cancer cells with mismatch repair-deficiency could help those with the disease treat ...

The investigational oral tyrosine kinase inhibitor (TKI) zongertinib showed promise in patients with previously treated HER2 ...

For a limited group of cancer patients who have solid tumors in the stomach, rectum, esophagus and other organs, an ...

Immunotherapy let some cancer patients with mismatch repair deficient tumors completely avoid surgery, chemo and radiation, a ...

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

Adding pembrolizumab (Keytruda), before and after surgery, to standard adjuvant therapy for locally advanced head and neck ...

AACR president received a standing ovation in rousing call to action for the cancer research community's response to funding ...

Cancer survivors who reported feeling cancer-related fatigue or depression reduced their recreational activities nearly ...

A Stage 4 cancer survivor is grateful for a 'lifesaving' clinical trial, but experts are wary over potential federal funding ...

Patients with advanced solid tumors experienced significantly improved survival outcomes when receiving a tailored therapy ...